Fortis Malar [FORTISMLR] vs Max Healthcare [MAXHEALTH] Detailed Stock Comparison
Fortis Malar
BSE
Loading...
Max Healthcare
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Fortis Malar wins in 8 metrics, Max Healthcare wins in 11 metrics, with 0 ties. Max Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Fortis Malar | Max Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 27.91 | 104.16 | Fortis Malar |
| Price-to-Book Ratio | 4.26 | 12.65 | Fortis Malar |
| Debt-to-Equity Ratio | 0.00 | 32.09 | Fortis Malar |
| PEG Ratio | 0.00 | 3.42 | Fortis Malar |
| EV/EBITDA | 166.65 | 61.63 | Max Healthcare |
| Profit Margin (TTM) | 22,483.90% | 15.27% | Fortis Malar |
| Operating Margin (TTM) | -1,572.20% | 20.65% | Max Healthcare |
| EBITDA Margin (TTM) | N/A | 20.65% | N/A |
| Return on Equity | 1.30% | 11.47% | Max Healthcare |
| Return on Assets (TTM) | 1.06% | 7.07% | Max Healthcare |
| Free Cash Flow (TTM) | $15.44M | $4.94B | Max Healthcare |
| Dividend Yield | 3.38% | 0.23% | Fortis Malar |
| 1-Year Return | 11.89% | 44.14% | Max Healthcare |
| Price-to-Sales Ratio (TTM) | 6,278.05 | 15.80 | Max Healthcare |
| Enterprise Value | $964.75M | $1,210.18B | Max Healthcare |
| EV/Revenue Ratio | 4,706.12 | 16.11 | Max Healthcare |
| Gross Profit Margin (TTM) | 100.00% | 78.04% | Fortis Malar |
| Revenue per Share (TTM) | $0 | $77 | Max Healthcare |
| Earnings per Share (Diluted) | $2.46 | $11.72 | Max Healthcare |
| Beta (Stock Volatility) | -0.08 | 0.33 | Fortis Malar |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Fortis Malar vs Max Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Fortis Malar | -0.36% | 0.23% | -3.60% | -8.27% | 17.31% | 11.57% |
| Max Healthcare | 1.47% | -2.48% | 0.92% | 3.48% | 20.59% | 7.88% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Fortis Malar | 11.89% | 18.57% | 40.49% | 54.71% | 104.98% | 296.37% |
| Max Healthcare | 44.14% | 224.64% | 998.17% | 1,000.13% | 1,000.13% | 1,000.13% |
Performance & Financial Health Analysis: Fortis Malar vs Max Healthcare
| Metric | FORTISMLR | MAXHEALTH |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.29B | ₹1.19T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 14,440 | 1,774,215 |
| 90 Day Avg. Volume | 14,545 | 1,760,853 |
| Last Close | ₹68.52 | ₹1,229.40 |
| 52 Week Range | ₹51.01 - ₹98.70 | ₹836.60 - ₹1,314.30 |
| % from 52W High | -30.58% | -6.46% |
| All-Time High | ₹107.94 (Apr 22, 2024) | ₹1,314.30 (Jul 04, 2025) |
| % from All-Time High | -36.52% | -6.46% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.31% |
| Quarterly Earnings Growth | N/A | 0.30% |
| Financial Health | ||
| Profit Margin (TTM) | 224.84% | 0.15% |
| Operating Margin (TTM) | -15.72% | 0.21% |
| Return on Equity (TTM) | 0.01% | 0.11% |
| Debt to Equity (MRQ) | 0.00 | 32.09 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹16.12 | ₹96.50 |
| Cash per Share (MRQ) | ₹17.19 | ₹6.81 |
| Operating Cash Flow (TTM) | ₹-10,605,000 | ₹13.02B |
| Levered Free Cash Flow (TTM) | ₹3.92M | ₹10.76B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.38% | 0.23% |
| Last 12-Month Dividend | ₹2.50 | ₹3.00 |
Valuation & Enterprise Metrics Analysis: Fortis Malar vs Max Healthcare
| Metric | FORTISMLR | MAXHEALTH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 27.91 | 104.16 |
| Forward P/E | N/A | 51.72 |
| PEG Ratio | 0.00 | 3.42 |
| Price to Sales (TTM) | 6,278.05 | 15.80 |
| Price to Book (MRQ) | 4.26 | 12.65 |
| Market Capitalization | ||
| Market Capitalization | ₹1.29B | ₹1.19T |
| Enterprise Value | ₹964.75M | ₹1.21T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4,706.12 | 16.11 |
| Enterprise to EBITDA | 166.65 | 61.63 |
| Risk & Other Metrics | ||
| Beta | -0.08 | 0.33 |
| Book Value per Share (MRQ) | ₹16.12 | ₹96.50 |
Financial Statements Comparison: Fortis Malar vs Max Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FORTISMLR | MAXHEALTH |
|---|---|---|
| Revenue/Sales | ₹205,000 | ₹20.28B |
| Cost of Goods Sold | ₹0 | ₹4.45B |
| Gross Profit | ₹205,000 | ₹15.82B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹42.85M | ₹4.19B |
| EBITDA | ₹42.85M | ₹5.59B |
| Pre-Tax Income | ₹42.85M | ₹4.00B |
| Income Tax | ₹1.32M | ₹924.60M |
| Net Income (Profit) | ₹41.53M | ₹3.08B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FORTISMLR | MAXHEALTH |
|---|---|---|
| Cash & Equivalents | ₹2.02M | ₹6.62B |
| Total Current Assets | ₹341.12M | ₹15.93B |
| Total Current Liabilities | ₹66.23M | ₹18.14B |
| Long-Term Debt | N/A | ₹27.68B |
| Total Shareholders Equity | ₹302.09M | ₹93.81B |
| Retained Earnings | ₹18.80M | ₹31.11B |
| Property, Plant & Equipment | ₹0 | ₹19.32B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FORTISMLR | MAXHEALTH |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FORTISMLR | MAXHEALTH |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 14,440 | 1,774,215 |
| Average Daily Volume (90 Day) | 14,545 | 1,760,853 |
| Shares Outstanding | 18.74M | 972.14M |
| Float Shares | 4.82M | 677.54M |
| % Held by Insiders | 0.72% | 0.24% |
| % Held by Institutions | 0.00% | 0.52% |
Dividend Analysis & Yield Comparison: Fortis Malar vs Max Healthcare
| Metric | FORTISMLR | MAXHEALTH |
|---|---|---|
| Last 12-Month Dividend | ₹2.50 | ₹3.00 |
| Last 12-Month Dividend Yield | 3.38% | 0.23% |
| 3-Year Avg Annual Dividend | ₹14.17 | ₹1.33 |
| 3-Year Avg Dividend Yield | 26.20% | 0.15% |
| 3-Year Total Dividends | ₹42.50 | ₹4.00 |
| Ex-Dividend Date | Jul 24, 2024 | Jul 04, 2025 |